Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users

Psychopharmacology (Berl). 2002 Jul;162(2):203-14. doi: 10.1007/s00213-002-1071-9. Epub 2002 May 9.

Abstract

Rationale: Experimental evidence has shown that 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") can act as a serotonergic neurotoxin in laboratory animals. The serotonin system predominantly innervates frontal and limbic regions of the brain and has been associated with consolidatory learning and mnemonic processes in humans.

Objectives: The aim of the present study was to investigate the cognitive neuropsychological profile of drug-free ecstasy users by employing a selection of tasks previously associated with lesion or neurodegenerative damage to the temporal lobe or fronto-striatal regions.

Methods: The study comprised 40 participants: 20 ecstasy polydrug users and 20 polydrug users who had never taken ecstasy.

Results: Ecstasy users were significantly impaired on a recognition task for complex visual patterns and spatial working memory, as a function of task difficulty rather than systematic search strategy. They also showed a trend towards impairment on several learning paradigms. Ecstasy users remained relatively unimpaired on most measures associated with prefrontal functioning, with the exception of verbal fluency "letter" generation.

Conclusions: Initial cognitive deficits in ecstasy polydrug users may be more apparent in tasks known to be sensitive to temporal functioning.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Association Learning / drug effects
  • Attention / drug effects
  • Cognition Disorders / chemically induced
  • Cognition Disorders / psychology*
  • Decision Making / drug effects
  • Female
  • Hallucinogens / adverse effects*
  • Hallucinogens / chemistry
  • Humans
  • Male
  • Memory / drug effects
  • Memory Disorders / chemically induced
  • Memory Disorders / psychology*
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • N-Methyl-3,4-methylenedioxyamphetamine / chemistry
  • Neuropsychological Tests
  • Space Perception / drug effects
  • Substance-Related Disorders / complications
  • Substance-Related Disorders / psychology*
  • Task Performance and Analysis
  • Temporal Lobe / drug effects*
  • Temporal Lobe / physiopathology
  • Verbal Behavior / drug effects

Substances

  • Hallucinogens
  • N-Methyl-3,4-methylenedioxyamphetamine